Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research Output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
PrevANZ: Phase IIb Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Trial of Vitamin D3 in Patients with a First Demyelinating Event.
Butzkueven, Helmut
(Primary Chief Investigator (PCI))
Department of Neuroscience
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
5/12/18
→
31/12/20
View all
View less